Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2011
Date:1/26/2012

SAN DIEGO, Jan. 26, 2012 /PRNewswire/ --ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended December 31, 2011.  Revenue for the quarter ended December 31, 2011 was $332.7 million, a 9% increase (also a 9% increase on a constant currency basis) over the quarter ended December 31, 2010.  For the quarter ended December 31, 2011, net income was $62.9 million, an increase of 8%, compared to the quarter ended December 31, 2010.  Diluted earnings per share for the quarter ended December 31, 2011 were $0.42, an increase of 14% compared to the quarter ended December 31, 2010.  

(Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

SG&A expenses were $100.6 million for the quarter ended December 31, 2011, an increase of $9.0 million, or 10% (a 9% increase on a constant currency basis) over the quarter ended December 31, 2010.  The increase in SG&A was primarily due to expenses necessary to support sales growth.  SG&A costs were 30% of revenue in the quarter ended December 31, 2011, compared to 30% in the quarter ended December 31, 2010.R&D expenses were $27.2 million for the quarter ended December 31, 2011, or 8% of revenue.  R&D expenses increased by 24% (a 21% increase on a constant currency basis) compared to the quarter ended December 31, 2010.  

The company amortized acquired intangibles of $3.7 million ($2.7 million, net of tax) during the quarter ended December 31, 2011.  Stock-based compensation costs incurred during the quarter ended December 31, 2011 of $7.4 million ($5.8 million, net of tax) consisted of expenses associated with stock options, restricted stock units, and our employee stock purchase plan.  

For the six months ended December 31, 2011, revenue was $647.5 m
'/>"/>

SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ResMed Announces Change to Outside US Dial-in Number for Conference Call and Webcast to Discuss Second Quarter 2012 Results
2. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
3. ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011
4. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
5. ResMed Inc. to Present at Upcoming Conferences
6. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
7. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
8. ResMed Announces Acquisition of BiancaMed
9. ResMed Announces New iPhone App
10. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
11. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015 /CNW/ - Export Development Canada (EDC) today announced a ... Montreal,s Valeant Pharmaceuticals International, Inc. (Valeant), ... The loan is part of a ... is using to fund the repayment of certain outstanding ... pharmaceutical company based in the US. Salix was acquired ...
(Date:5/26/2015)... 26, 2015  Haemonetics Corporation (NYSE: HAE ) ... Investor Relations, will present at The East Coast IDEAS ... June 4 th , 2015 at 2:30pm Eastern time.  ... presentation live via webcast at: http://www.wsw.com/webcast/threepa16/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/26/2015)... May 26, 2015  Amgen (NASDAQ: AMGN ) ... Phase 3 OPTiM study in the Journal of ... data published in JCO , which were previously ... of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated ... with unresected stage IIIB, IIIC or IV metastatic melanoma ...
Breaking Medicine Technology:EDC provides Valeant Pharmaceuticals with USD 67.5 M to support recent Salix Pharmaceuticals acquisition 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8
... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... products for central nervous system disorders, today announced it will ... May 5, 2011, before the market opens. A full text ... Mihael H. Polymeropoulos, M.D., President and Chief Executive ...
... NEW BRAUNFELS, Texas, April 22, 2011 One hundred and ... challenge bike riders in the BP MS 150 overcame on ... Sclerosis. Team Freedom, a corporate team sponsored by The ... solutions and services, completed the two-day ride and raised nearly ...
Cached Medicine Technology:Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011 2The SCOOTER Store Supports Fight Against Multiple Sclerosis 2
(Date:5/27/2015)... One of America's most cherished actors, James Earl ... that takes a look at the topic of atrial ... abnormal heart rhythm. Those who suffer from atrial fibrillation ... too quickly. , This new segment will take a ... to inform viewers about possible signs that commonly indicate ...
(Date:5/27/2015)... 27, 2015 The Academy of Oncology ... Coast Regional Meeting in Seattle. This intimate gathering, held ... 200 navigation and oncology professionals from west of the ... , “One of the most important things that an ... their needs and do the best it can to ...
(Date:5/26/2015)... 27, 2015 Carey Danis & ... testosterone gel lawsuit . The suit pertains to AndroGel, ... was filed in late April 2015, and a court ... Illinois federal court in mid-May.¹ , Testosterone gel lawsuits ... the Northern District of Illinois. The multidistrict litigation (MDL) ...
(Date:5/26/2015)... Readers who struggle with memory , ... Chester Litvin ’s new book, “ Introduction to ... Trafford Publishing). , Litvin, who is a clinical psychologist, ... This book will guide readers through a series of ... cells . He shares his patented process for reviving ...
(Date:5/26/2015)... Liverpool, Ohio (PRWEB) May 26, 2015 Mr. ... role since 2010, will start working together this week to ... an accomplished career in healthcare executive leadership and strategy. ... CEO prior to the hiring of Mr. Cochran. The Board ... skills will complement the improvement strategies implemented over the past ...
Breaking Medicine News(10 mins):Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 2Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 3Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3
... Harvard Medical School, of more than 100,000 women, indicates ... either psychiatric// illnesses or other conditions, may have an ... about 52,000 women who were taking dopamine antagonists and ... compared for breast cancer rates. It was found that ...
... of Nature Medicine by researchers in Rene Descartes University has ... vaccine which may one day let people quit their AIDS ... promising results, and if confirmed and adapted in humans may ... researchers reported that the new vaccine uses a type of ...
... age people are now increasingly taking to gardening as a ... of beautiful gardens. Though gardening has been proven to have ... gardeners who start with little or no idea of how ... up having severe back pain. ,A recent study of ...
... published in the British Medical Journal suggests that there is ... of their offspring. In contrast to overweight children given birth ... are likely to weigh less than other children. ... 186 grams less than other children and this significant difference ...
... ancient Chinese medical practices that has gained widespread ... suggest that along with other therapies, the traditional ... paediatric patients. ,A recent study which shows ... to acupuncturists, proves the popularity of the traditional ...
... Dietary Supplements & Diabetes ,A recent ... conducted by Dr.Vijay Jayagopal and his colleagues from the ... understand the benefits of dietary supplements on type 2 ... menopausal women with type 2 diabetes who //either received ...
Cached Medicine News:Health News:A Compilation of recent Diabetes Research articles 2
... the best of both worlds, the ... is the latest addition to the ... bipolar cautery instruments for ophthalmic surgery. ... extrusion aspiration and backflush functionality in ...
...
...
...
Medicine Products: